- Goals of Treatment, Indication, and Treatment for Chronic Hepatits C
-
Paik SW
- KMID: 1767541
- Korean J Gastroenterol.
- 2008 Jun;51(6):368-371.
Hepatitis C virus (HCV) is a major cause of chronic hepatitis and hepatic fibrosis worldwide. Up to 85% of individuals infected with HCV develop chronic infection, which can progress to... -
- CITED
-
- Close
- SHARE
-
- Close
- A case report of treatment with pegylated interferon alpha for lamivudine-resistant chronic hepatitis B virus infection
-
Hur WH, Woo HY, Jeong SW, You CR, Bae SH, Choi JY, Yoon SK
- KMID: 1073303
- Korean J Hepatol.
- 2008 Dec;14(4):513-518.
- doi: 10.3350/kjhep.2008.14.4.513
The wide use of lamivudine in chronic hepatitis B has produced a monotonic increase in patients with lamivudine resistance. Therefore, treating lamivudine resistance in chronic hepatitis B is a major... -
- CITED
-
- Close
- SHARE
-
- Close
- Durability of Sustained Virologic Response in Chronic Hepatitis C: Analysis of Factors Related to Relapse after Sustained Virologic Response with Peginterferon Plus Ribavirin Combination Therapy
-
Lee JE, Yoon NR, Kim JD, Song MJ, Kwon JH, Bae SH, Choi JY, Jeong SW, Yoon SK
- KMID: 1128356
- Korean J Gastroenterol.
- 2011 Mar;57(3):173-179.
- doi: 10.4166/kjg.2011.57.3.173
BACKGROUND/AIMS: Pegylated interferon plus ribavirin combination therapy has been the standard of therapy for patients with chronic hepatitis C. Although previous studies have reported long term durability after the sustained... -
- CITED
-
- Close
- SHARE
-
- Close
- Durability of a sustained virologic response in combination therapy with interferon/peginterferon and ribavirin for chronic hepatitis C
-
Kim CH, Park BD, Lee JW, Kim YS, Jeong S, Lee DH, Kim HG, Shin YW, Kwon KS, Lee JI
- KMID: 1776816
- Korean J Hepatol.
- 2009 Mar;15(1):70-79.
- doi: 10.3350/kjhep.2009.15.1.70
BACKGROUNDS/AIMS: The ultimate goal of antiviral therapy using interferon/pegylated interferon combined with ribavirin in chronic C-viral hepatitis is to achieve a sustained virologic response (SVR). Several studies have shown that... -
- CITED
-
- Close
- SHARE
-
- Close
- Mutations within the interferon sensitivity determining region in Korean patients infected with hepatitis C virus genotype 1b
-
Jin YJ, Park YK, Yun GJ, Lee HC, Jeong SH, Kim GM, Lim YS, Chung YH, Lee YS, Suh DJ
- KMID: 1792594
- Korean J Hepatol.
- 2010 Jun;16(2):158-167.
- doi: 10.3350/kjhep.2010.16.2.158
BACKGROUND/AIMS: The treatment response to interferon could differ with mutations in the interferon-sensitivity-determining region (ISDR) in patients infected with hepatitis C virus (HCV) genotype-1b (HCV-Ib). We examined the pattern of... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of adherence to peginterferon-ribavirin combination therapy in chronic hepatitis C patients on achieving a sustained virologic response
-
Jeong SW, Kim JD, Woo HY, You CR, Lee SW, Song MJ, Jang JW, Bae SH, Choi JY, Yoon SK
- KMID: 1374962
- Korean J Hepatol.
- 2009 Sep;15(3):338-349.
- doi: 10.3350/kjhep.2009.15.3.338
BACKGROUND/AIMS: Various predictive factors for peginterferon alpha and ribavirin therapy in chronic hepatitis C have been reported, but the effect of adherence to therapy has not been established. We investigated... -
- CITED
-
- Close
- SHARE
-
- Close
- Importance of Medication Adherence to Peginterferon-Ribavirin Combination Therapy in Patients with Chronic Hepatitis C
-
Goh PG, Kim MJ, Kim HJ, Eun HS, Kim ES, Kim YJ, Lee SY, Moon HS, Lee ES, Kim SH, Lee BS, Lee HY
- KMID: 1792786
- Korean J Gastroenterol.
- 2011 May;57(5):294-301.
- doi: 10.4166/kjg.2011.57.5.294
BACKGROUND/AIMS: The combination therapy with peginterferon and ribavirin is a standard treatment for patients with chronic hepatitis C. However, because of the long duration of the treatment and many complications,... -
- CITED
-
- Close
- SHARE
-
- Close
